Jiangsu Pengyao Pharmaceutical

Jiangsu Pengyao Pharmaceutical is a comprehensive pharmaceutical formulation company based in Yixing, Jiangsu Province, China. Originally established in 1973 as the Yixing Pharmaceutical Factory, the company has grown into a prominent regional manufacturer of both chemical generics and traditional Chinese medicines. Its extensive product portfolio covers therapeutic areas such as anti-infectives, cardiovascular diseases, gastroenterology, and oncology, with multiple formulations across tablets, capsules, injections, and oral liquids. In 2020, the company established the Pengyao New Drug Innovation Center to advance its research and development capabilities in chemical drugs, traditional Chinese medicine, and health supplements. The company operates modern GMP-certified manufacturing facilities and distributes its products both domestically within China and to international markets, including regions in Africa and Latin America.